Related Experiment Video
Updated: May 20, 2026

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection
Published on: August 20, 2007
Losing ground: multidrug-resistant bacteria in solid-organ transplantation
Ramin S Herati1, Emily A Blumberg
1Division of Infectious Diseases, Department of Medicine, Hospital of University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Multidrug-resistant (MDR) bacterial infections are a growing threat in solid-organ transplant recipients. Early recognition and tailored antibiotic selection are crucial for managing these complex posttransplant infections and reducing mortality.
Area of Science:
- Infectious Diseases
- Transplantation Medicine
- Microbiology
Background:
- Solid-organ transplant recipients are highly susceptible to infections due to prolonged immunosuppression.
- Multidrug-resistant (MDR) bacteria pose a significant and increasing threat in this vulnerable population.
- Posttransplant infections caused by MDR bacteria can lead to severe complications and increased mortality.
Purpose of the Study:
- To review the role and impact of multidrug-resistant bacteria in infections following solid-organ transplantation.
- To highlight the challenges in diagnosing and treating MDR bacterial infections in transplant patients.
- To emphasize the importance of prompt recognition and appropriate antimicrobial therapy.
Main Methods:
- This is a review article, synthesizing current literature on MDR bacterial infections in solid-organ transplant recipients.
- The review analyzes incidence, causative organisms, risk factors, and transmission routes.
- Key aspects of diagnosis, treatment, and prevention strategies are discussed.
Main Results:
- The incidence of MDR bacterial infections in solid-organ transplant recipients is steadily increasing.
- Infection patterns vary significantly based on transplanted organ, geographic location, and patient-specific risk factors.
- Transmission of MDR bacteria via the transplanted organ, though rare, is a critical consideration.
Conclusions:
- MDR bacterial infections in solid-organ transplant recipients are diverse and necessitate careful antibiotic selection.
- Prompt identification and early, appropriate treatment are vital to improve outcomes and reduce mortality.
- High-risk patients may benefit from broad-spectrum antibiotic coverage to facilitate timely antimicrobial therapy.
More Related Videos
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Clinical Significance of Antibiotic Resistance
Kidney Transplant II: Surgical Procedure
Mechanism of Antibiotic Resistance in MRSA
Kidney Transplant III: Nursing Management
